SABBY 13G ARWR 03.13.13

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

May 13, 2013

Accession Number

0001535610-13-000037

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →